No Prescription

No Prescription
HomeAlpha IndexCategories

Allergy

Anti Bacterial

Anti Convulsants

Anti Depressants

Anti Fungal

Anti Narcoleptic

Anti Viral

Antibiotics

Arthritis

Asthma

Birth Control

Blood Pressure

Cancer

Cardiovascular

Cholesterol

Diabetes

Diuretics

Eye Drops

Gastrointestinal

Hair Care

Herbal & Diet Supplements

Men's Health

Migraines

Muscle Relaxers

Nausea & Vomiting

Other

Pain Medicine

Pet Herbal Remedies

Prescription Drugs 1

Prescription Drugs 2

Prescription Drugs 3

Prescription Drugs 4

Prescription Drugs 5

Prescription Drugs 6

Prescription Drugs 7

Prescription Drugs 8

Prescription Drugs 9

Prescription Drugs 10

Prescription Drugs 11

Prescription Drugs 12

Prescription Drugs 13

Prescription Drugs 14

Prescription Drugs 15

Prescription Drugs 16

Prescription Drugs 17

Respiratory

Skin Care

Stop Smoking

Thyroid

Weight Loss

Women's Health

No Prescription

Alphabetical Index

Categories

Zerit (Stavudine)

No Prescription » Anti Viral » Zerit (Stavudine)

Zerit (Stavudine) is a nucleoside analogue antiviral used in combination with other medicines to manage Human Immunodeficiency Virus (HIV) infection.

Buy Zerit (Stavudine) and other Anti Viral products online at Medstore.

Buy Online at Medstore - Click Here!

About Zerit (Stavudine):

Product Type: Anti Viral

Brand name: Zerit Generic name: Stavudine What is the most important information I should know about Zerit? • Lactic acidosis and severe liver problems including fatal cases have been reported with the use of reverse transcriptase inhibitors such as Zerit alone or in combination. Contact your doctor immediately if you experience nausea vomiting or unusual or unexpected stomach discomfort; weakness and tiredness; shortness of breath; weakness in the arms and legs; yellowing of the skin or eyes; or pain in the upper stomach area. These may be early symptoms of lactic acidosis or liver problems. • Serious cases of pancreatitis (inflammation of the pancreas) have been reported with the use of Zerit. Notify your doctor immediately if you develop symptoms of pancreatitis including nausea vomiting diarrhea abdominal pain. • Avoid alcohol while taking Zerit. Alcohol may increase the risk of damage to the pancreas and/ or liver. • The most common side effect from Zerit therapy is peripheral neuropathy which may cause loss of feeling numbness tingling or pain in a part of the body. Approximately 20% of patients taking Zerit will experience peripheral neuropathy. Contact your doctor if you experience any of these side effects. • Follow your doctor's instructions with respect to high-risk activities such as unprotected sex and the sharing of needles. Zerit is not a cure for HIV or AIDS and you can still transmit the virus to others during therapy with this medication. What is Zerit? • Zerit is an antiviral medication. It is in a category of HIV medicines called reverse transcriptase inhibitors. Zerit inhibits the reproduction of HIV in the body. • Zerit is used to treat the human immunodeficiency virus (HIV) which causes the acquired immunodeficiency syndrome (AIDS). Zerit is not a cure for HIV or AIDS. • Zerit may also be used for purposes other than those listed in this medication guide. What should I discuss with my healthcare provider before taking Zerit? • Before taking Zerit tell your doctor if you have: kidney disease; liver disease; pancreatitis; or a history of peripheral neuropathy (numbness or tingling). or • You may not be able to take Zerit or you may require a dosage adjustment or special monitoring during treatment if you have any of the conditions listed above. • The Zerit oral solution contains 50 mg of sucrose per mL. Individuals with diabetes may need to monitor their intake of sucrose. • Zerit is in the FDA pregnancy category C. This means that it is not known whether it will harm an unborn baby. Fatal lactic acidosis has been reported in pregnant women treated with the combination of didanosine (Videx Videx EC) and Zerit with other antiretroviral medicines. It is very important to treat HIV/ AIDS during pregnancy to reduce the risk of infecting the baby. Talk to your doctor about your treatment options. • It is not known whether Zerit passes into breast milk and what effect it may have on a nursing baby. To prevent transmission of the virus to uninfected babies it is recommended that HIV-positive mothers not breast-feed. Talk to your doctor about breast-feeding if you are taking Zerit. How should I take Zerit? • Take Zerit exactly as directed by your doctor. If you do not understand these directions ask your pharmacist nurse or doctor to explain them to you. • Take each dose with a full glass of water. • Zerit can be taken with or without food. • Shake the suspension well before measuring a dose. • To ensure that you get a correct dose measure the liquid form of Zerit with a special dose-measuring spoon or cup not with a regular table spoon. If you do not have a dose-measuring device ask your pharmacist for one. • Swallow the extended-release capsules (Zerit XR) whole without crushing or chewing. If swallowing the capsules is difficult they can be carefully opened and the contents mixed with two tablespoons of applesauce or yogurt. The mixture should then be swallowed whole without chewing or crushing the beads. Consume the mixture immediately do not save it for later use. • Treatment of HIV/ AIDS almost always requires the use of two or more drugs. If you need to stop taking one of the medicines you are taking for HIV you should stop all of them until you can talk to your doctor. • It is important to take Zerit regularly to get the most benefit. • Your doctor may want you to have blood tests or other medical evaluations during treatment with Zerit to monitor progress and side effects. • Store Zerit capsules at room temperature away from moisture and heat. • Store the Zerit suspension in the refrigerator between 2 and 8 degrees Celsius (36 to 46 degrees Fahrenheit). Throw away any unused suspension after 30 days. What happens if I miss a dose? • Take the missed dose as soon as you remember. However if it is almost time for the next regularly scheduled dose skip the missed dose and take the next one as directed. Do not take a double dose of this medication unless your doctor directs otherwise. What happens if I overdose? • Seek emergency medical attention. • Symptoms of a Zerit overdose include liver damage (yellowing of the skin or eyes nausea abdominal pain or discomfort unusual bleeding or bruising severe fatigue) and numbness tingling or pain in a part of the body. What should I avoid while taking Zerit? • Follow your doctor's instructions with respect to high-risk activities such as unprotected sex and the sharing of needles. Zerit is not a cure for HIV or AIDS and you can still transmit the virus to others during therapy with this medication. • Avoid alcohol while taking Zerit. Alcohol may increase the risk of damage to the pancreas and/ or liver. What are the possible side effects of Zerit? • Stop taking Zerit and seek emergency medical attention if you experience an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips tongue or face; or hives). • Lactic acidosis and severe liver problems including fatal cases have been reported with the use of reverse transcriptase inhibitors such as Zerit alone or in combination. Contact your doctor immediately if you experience nausea vomiting or unusual or unexpected stomach discomfort; weakness and tiredness; shortness of breath; weakness in the arms and legs; yellowing of the skin or eyes; or pain in the upper stomach area. These may be early symptoms of lactic acidosis or liver problems. • Serious cases of pancreatitis (inflammation of the pancreas) have been reported with the use of Zerit. Notify your doctor immediately if you develop symptoms of pancreatitis including nausea vomiting diarrhea abdominal pain. • The most common side effect from Zerit therapy is peripheral neuropathy which may cause loss of feeling numbness tingling or pain in a part of the body. Approximately 20% of patients taking Zerit will experience peripheral neuropathy. Contact your doctor if you experience any of these side effects. • Other less serious side effects may be more likely to occur. Continue to take Zerit and talk to your doctor if you experience any of the following side effects: headache; a fever or chills; nausea vomiting or diarrhea; insomnia; decreased appetite; a rash; or redistribution of body fat (loss of fat from the arms legs and face and increased fat around the neck breast and trunk). • Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. What other drugs will affect Zerit? • Zerit may interact with other medications resulting in reduced effectiveness and/ or side effects. Talk to your doctor and pharmacist before taking any other prescription or over-the-counter medications including herbal products

Generic Zerit (Stavudine)

Stavir

30mg 120 caps 30mg 240 caps 40mg 240 caps 30mg 30 caps 40mg 30 caps 30mg 60 caps 40mg 60 caps 30mg 90 caps 40mg 90 caps 40mg 120 caps Stavudine Zerit

View more Anti Viral

Previous Product  Next Product

No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.